Chemoinformaics analysis of 2-(2-CHLORO-5-OXOFURAN-2-YL)ACETIC ACID
Molecular Weight | 176.555 | nRot | 2 |
Heavy Atom Molecular Weight | 171.515 | nRig | 14 |
Exact Molecular Weight | 175.988 | nRing | 1 |
Solubility: LogS | -3.676 | nHRing | 1 |
Solubility: LogP | 2.136 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 5 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 18.742 |
nHD | 1 | BPOL | 8.99804 |
QED | 0.482 |
Synth | 2.811 |
Natural Product Likeliness | 1.24 |
NR-PPAR-gamma | 0.077 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.003 |
Pgp-sub | 0.118 |
HIA | 0.011 |
CACO-2 | -4.749 |
MDCK | 0.0000184 |
BBB | 0.03 |
PPB | 0.812272 |
VDSS | 1.092 |
FU | 0.12874 |
CYP1A2-inh | 0.976 |
CYP1A2-sub | 0.952 |
CYP2c19-inh | 0.637 |
CYP2c19-sub | 0.524 |
CYP2c9-inh | 0.216 |
CYP2c9-sub | 0.812 |
CYP2d6-inh | 0.66 |
CYP2d6-sub | 0.819 |
CYP3a4-inh | 0.637 |
CYP3a4-sub | 0.408 |
CL | 9.012 |
T12 | 0.616 |
hERG | 0.009 |
Ames | 0.696 |
ROA | 0.085 |
SkinSen | 0.392 |
Carcinogencity | 0.894 |
EI | 0.211 |
Respiratory | 0.903 |
NR-Aromatase | 0.435 |
Antiviral | No |
Prediction | 0.885507 |